Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Tamiko Tamanaha"'
Autor:
Yu Kataoka, Satoshi Kitahara, Sayaka Funabashi, Hisashi Makino, Masaki Matsubara, Miki Matsuo, Yoko Omura-Ohata, Ryo Koezuka, Mayu Tochiya, Tamiko Tamanaha, Tsutomu Tomita, Kyoko Honda-Kohmo, Michio Noguchi, Kota Murai, Kenichiro Sawada, Takamasa Iwai, Hideo Matama, Satoshi Honda, Masashi Fujino, Kazuhiro Nakao, Shuichi Yoneda, Kensuke Takagi, Fumiyuki Otsuka, Yasuhide Asaumi, Kiminori Hosoda, Stephen J. Nicholls, Satoshi Yasuda, Teruo Noguchi
Publikováno v:
Atherosclerosis Plus, Vol 56, Iss , Pp 1-6 (2024)
Background and aims: Randomized clinical trials have demonstrated the ability of glucagon-like peptide-1 analogues (GLP-1RAs) to reduce atherosclerotic cardiovascular disease events in patients with type 2 diabetes (T2D). How GLP-1RAs modulate diabet
Externí odkaz:
https://doaj.org/article/409a421a06d648bab589ebcb9fd6fd88
Autor:
Mayu Tochiya, Hisashi Makino, Tamiko Tamanaha, Yoko Omura‐Ohata, Masaki Matsubara, Ryo Koezuka, Michio Noguchi, Tsutomu Tomita, Yasuhide Asaumi, Yoshihiro Miyamoto, Satoshi Yasuda, Kiminori Hosoda
Publikováno v:
ESC Heart Failure, Vol 10, Iss 2, Pp 1158-1169 (2023)
Abstract Aims The relationship between diabetic microvascular complications and the incidence of two types of heart failure—heart failure with reduced ejection fraction (HFrEF) (left ventricular ejection fraction [LVEF]
Externí odkaz:
https://doaj.org/article/0c5851a531b24346b0288d48f1fe6f56
Autor:
Masaki Matsubara, Tomohiro Tanaka, Akinori Wakamiya, Tamiko Tamanaha, Hisashi Makino, Tomonori Tanei, Takeshi Aiba, Kengo Kusano, Kiminori Hosoda
Publikováno v:
Case Reports in Endocrinology, Vol 2022 (2022)
A 48-year-old man who was diagnosed with arrhythmogenic right ventricular cardiomyopathy (ARVC) due to a plakophilin 2 gene mutation developed acute both-sided heart failure with rapid atrial fibrillation and was hospitalized. After admission, sustai
Externí odkaz:
https://doaj.org/article/50c303b15ce14046a5c7fa8a33565f5a
Autor:
Mayu Tochiya, Hisashi Makino, Tamiko Tamanaha, Miki Matsuo, Ai Hishida, Ryo Koezuka, Yoko Ohata, Tsutomu Tomita, Choel Son, Yoshihiro Miyamoto, Satoshi Yasuda, Kiminori Hosoda
Publikováno v:
Journal of Diabetes Investigation, Vol 11, Iss 2, Pp 400-404 (2020)
Abstract Recent studies have shown that sodium–glucose cotransporter 2 inhibitors decrease the risk of heart failure in patients with type 2 diabetes. However, the precise mechanisms of action of these drugs are not well understood. In the present
Externí odkaz:
https://doaj.org/article/f6b8db34ccca4270b798ea76b031b24e
Autor:
Yoko Omura-Ohata, Cheol Son, Hisashi Makino, Ryo Koezuka, Mayu Tochiya, Tamiko Tamanaha, Ichiro Kishimoto, Kiminori Hosoda
Publikováno v:
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-8 (2019)
Abstract Background Visceral fat area (VFA) is a good surrogate marker of obesity-related disorders, such as hypertension, dyslipidemia and glucose intolerance. Although estimating the VFA by X-ray computed tomography (CT) is the primary index for vi
Externí odkaz:
https://doaj.org/article/abac68cd722f47c38163a96cd2e5819e
Autor:
Yoko Ohata, Hisashi Makino, Yoshihiro Miyamoto, Cheol Son, Kazuo Washida, Masafumi Ihara, Masaki Matsubara, Ryo Koezuka, Kunihiro Nishimura, Tamiko Tamanaha, Kyoko Honda-Kohmo, Miki Matsuo, Michio Noguchi, Kiminori Hosoda, Michikazu Nakai, Tsutomu Tomita
Publikováno v:
Diabetes Therapy
Introduction Although the risk of dementia among patients with type 2 diabetes mellitus (T2DM) is double that of those without T2DM, the mechanism remains to be elucidated and the glycemic goal to prevent progression of cognitive impairment is unclea
Autor:
Gerald Watts, Farrah Deeba, David Sullivan, Paul Donald Bonnitcha, San San Min, Nimalie Jacintha Nanayakkara, Christopher Ebenbichler, Alexander Tschoner, Clemens Engler, Daniel Gaudet, Nathalie Roy, David Blackburn, Jean Bergeron, Hisee Villeneuve, Samir Saheb, Antonio Gallo, Sophia Beliard, Bertrand Dussol, Sophie Morange, Pascale Poullin, Rene Valero, Charalampos Milionis, Sebastian Filippas-Ntekouan, Eleftherios Klouras, Genovefa Kolovou, George Hatzigeorgiou, Spyridon Rammos, Paolo Rubba, Gabriella Iannuzzo, Mariko Harada-Shiba, Cheol Son, Hisashi Makino, Kiminori Hosoda, Kota Matsuki, Kyoko Kohmo, Masaki Matsubara, Masatsune Ogura, Michio Noguchio, Miki Matsuo, Ryo Koezuka, Tamiko Tamanaha, Tsutomu Tomita, Yoko Ohata, Yoshihiko Otsubo, Noriaki Koyanagi, Masaaki Kawashiri, Hayato Tada, Atsushi Nohara, Akihiro Nomura, Hirofumi Okada, Naohiko Fujii, Daisuke Hayashi, Sayoko Yonemoto, Shungo Fukuda, Koji Yanagi, Miwa Ryo, Masahiro Koseki, Makoto Nishida, Takeshi Okada, Erik Stroes, Laurens Reeskamp, Daniela Stols-Goncalves, Eva Hamulyak, Anho H Liem, Jurgen M Akkerhuis, Pieter R Nierop, Bastiaan M van Dalen, Sweder W E van de Poll, Adriana J M van Miltenburg-van Zijl, Marinus J Veerhoek, Frederick Raal, Sindeep Amrat Bhana, Olena Mitchenko, Vadym Romanov, Iryna Chulaevska, Leonid Rudenko, Olena Beregova, Igor Vakaliuk, Iryna Drapchak, Natalia Tymochko, Anna Isayeva, Olena Buriakovska, Maryna Vovchenko, Vira Tseluyko, Nataliya Matviychuk, Larysa Yakovleva, Paul Duell, Jonathan Barton Purnell, Robert Rosenson, Donald Smith, Theresa Halloran, Robert Gottlieb, Peter A McCullough, Zachary P Rosol, Andy Y Lee, Clay M Barbin, Seth J Baum, Reina Mendelson, Melissa Wright, Linda Hemphill, Akl Fahed, Traci Turner, Angela Ellard
Publikováno v:
New England journal of medicine, 383(8), 711-720. Massachussetts Medical Society
BACKGROUND: Homozygous familial hypercholesterolemia is characterized by premature cardiovascular disease caused by markedly elevated levels of low-density lipoprotein (LDL) cholesterol. This disorder is associated with genetic variants that result i
Autor:
Yu Kataoka, Yoshihiro Miyamoto, Satoshi Yasuda, Hisashi Makino, Masaki Matsubara, Teruo Noguchi, Ryo Koezuka, Yasuhide Asaumi, Michio Noguchi, Kiminori Hosoda, Tsutomu Tomita, Miki Matsuo, Yoko Ohata, Kunihiro Nishimura, Cheol Son, Tamiko Tamanaha, Kyoko Honda-Kohmo
Publikováno v:
Cardiovascular Diagnosis and Therapy. 9:431-438
Background: Patients with type 2 diabetes mellitus (T2DM) are high-risk subjects who more frequently have micro- and macrovascular diseases including coronary artery disease (CAD). Since impaired glycemic homeostasis directly influences the formation
Autor:
Tsutomu Tomita, Kiminori Hosoda, Satoshi Yasuda, Choel Son, Ai Hishida, Ryo Koezuka, Yoko Ohata, Yoshihiro Miyamoto, Hisashi Makino, Miki Matsuo, Mayu Tochiya, Tamiko Tamanaha
Publikováno v:
Journal of Diabetes Investigation
Journal of Diabetes Investigation, Vol 11, Iss 2, Pp 400-404 (2020)
Journal of Diabetes Investigation, Vol 11, Iss 2, Pp 400-404 (2020)
Recent studies have shown that sodium–glucose cotransporter 2 inhibitors decrease the risk of heart failure in patients with type 2 diabetes. However, the precise mechanisms of action of these drugs are not well understood. In the present study, we
Autor:
Masatsune Ogura, Mariko Harada-Shiba, Ryo Koezuka, Kota Matsuki, Kiminori Hosoda, Hisashi Makino, Tamiko Tamanaha
Publikováno v:
Journal of Atherosclerosis and Thrombosis
Lipoprotein apheresis has been developed as the treatment for refractory familial hypercholesterolemia (FH) to remove low-density lipoprotein (LDL), which is the main pathogenic factor. Currently, three procedures are available in Japan, including th